Trial Profile
Exploratory Evaluation of Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients Treated With HAART (CD4+ ≥ 200 Cells mm3): An Open Labeled, Non-Comparative Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Genital warts
- Focus Therapeutic Use
- Sponsors Meda Pharma GmbH & Co KG
- 16 Oct 2008 New trial record.